Study of ZIO-201 in Advanced Sarcoma

Alaunos Therapeutics

Status and phase: Completed; Phase 2; Phase 1

Conditions: Advanced Sarcoma

Treatments: Drug: ZIO-201

Study type: Interventional

Funder types: Industry

Identifiers

NCT00439686

IPM2001

Details and patient eligibility

About

The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.

Enrollment: 53 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Metastatic and /or unresectable disease state after previous standard chemotherapy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

53 participants in 1 patient group

Single Arm

Experimental group

Treatment:

Drug: ZIO-201